Jia Jie Biomedical Co Ltd (4109) — Capital Reinvestment Ratio
Jia Jie Biomedical Co Ltd (4109) has a Capital Reinvestment Ratio of 0.45x as of March 2026, meaning it reinvests 0% of its operating cash flow (NT$12.96 Million) in capital expenditures (NT$5.84 Million). Check Jia Jie Biomedical Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jia Jie Biomedical Co Ltd Capital Reinvestment Ratio (2015–2025)
This chart tracks Jia Jie Biomedical Co Ltd's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see Jia Jie Biomedical Co Ltd operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Jia Jie Biomedical Co Ltd (2015–2025)
Year-by-year Capital Reinvestment Ratio for Jia Jie Biomedical Co Ltd from 2015 to 2025. See 4109 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.01x | NT$21.34 Million | NT$85.50 Million | ▲ +805.1% |
| 2024 | 0.44x | NT$44.35 Million | NT$19.63 Million | ▲ +27.4% |
| 2021 | 0.35x | NT$4.37 Million | NT$1.52 Million | ▲ +476.4% |
| 2020 | 0.06x | NT$27.10 Million | NT$1.63 Million | ▼ -51.2% |
| 2019 | 0.12x | NT$24.71 Million | NT$3.05 Million | ▼ -96.3% |
| 2015 | 3.33x | NT$82.22 Million | NT$273.85 Million | — |